论文部分内容阅读
目的探讨针对初诊2型糖尿病患者，观察选择甘舒霖30R+二甲双胍完成治疗后的临床效果表现。方法选取我院2010年01月01日~2014年10月01日初诊2型糖尿病患者206例。通过随机数表法完成2型糖尿病患者的随机分组。 C1组(观察组103例)：临床选择甘舒霖30R+二甲双胍进行治疗；C2组(对照组103例)：临床选择甘舒霖30R进行治疗。对比两组糖尿病患者在FPG以及2hPG指标等方面表现出的差异性。结果两组2型糖尿病患者完成治疗后，在FPG(空腹血糖)指标以及2hPG(餐后2h血糖)指标两方面，同治疗前进行比较，表现为显著下降(<0.05)；C1组下降程度高于C2组患者明显(<0.05)。在血糖达标时间方面，C1组少于C2组患者明显(0.05)。结论针对初诊2型糖尿病患者，临床选择甘舒霖30R+二甲双胍进行治疗，能够有效保证患者的治疗安全性，在缩短患者血糖达标时间等方面表现出显著意义。“,”Objective To investigate the in newly diagnosed type 2 diabetic patients, the clinical ef ect observed choice Gan Shulin 30R+ metformin after completing treatment. Methods Selected in our hospital in 2010 01 on Sept. 01~ October 1, 2014 in newly diagnosed type 2 diabetic patients in 206 cases. Complete randomized grouping in patients with type 2 diabetes mel itus by random number table method. C1 group (observation group 103 cases):clinical choice Gan Shulin 30R+ metformin treatment;group C2 (control group 103 cases):clinical choice Gan Shulin 30R treatment. Comparison between two groups of diabetic patients in the FPG and 2hPG index show etc. Results The two groups of patients with type 2 diabetes mel itus after completing treatment, in FPG (fasting blood glucose) index (2H and 2hPG postprandial blood glucose) in two indexes, compared with before treatment, showed decreased significantly ( <0.05); C1 group decreased obviously in the patients of group C2 significantly ( <0.05). In the glucose standard time, group C1 was less than that in C2 group were significantly ( 0.05). Conclusion For newly diagnosed patients with type 2 diabetes, clinical choice Gan Shulin 30R+metformin treatment, can ef ectively guarantee the safety of treatment of patients, showed significance in shortening the patients blood glucose time etc.